Arzu Gunes

1.1k total citations
23 papers, 832 citations indexed

About

Arzu Gunes is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Arzu Gunes has authored 23 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pharmacology. Recurrent topics in Arzu Gunes's work include Pharmacogenetics and Drug Metabolism (6 papers), Schizophrenia research and treatment (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Arzu Gunes is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Schizophrenia research and treatment (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Arzu Gunes collaborates with scholars based in Sweden, Türkiye and New Zealand. Arzu Gunes's co-authors include Marja‐Liisa Dahl, Maria Gabriella Scordo, Kristina Melkersson, Edoardo Spina, Hakan Zengil, M.G. Scordo, P. Ruygrok, Gül Özbey, Seif El‐Jack and Douglas Scott and has published in prestigious journals such as The FASEB Journal, Psychopharmacology and The Journal of Clinical Psychiatry.

In The Last Decade

Arzu Gunes

23 papers receiving 809 citations

Peers

Arzu Gunes

PHARM

PMH

PHARM

CCM

Jesús Novalbos Spain

S Freestone United Kingdom

Mohamed E. E. Shams Egypt

Pablo Zubiaur Spain

D R Abernethy United States

U. Jeppesen Denmark

Mila Lovrić Croatia

Soong T. Chiang United States

Marleen Depré Belgium

David W. J. Clark New Zealand

Jesús Novalbos Spain

Arzu Gunes

217 ×0.8

PHARM

170 ×0.8

PMH

125 ×0.7

PHARM

101 ×0.6

CCM

162 ×1.2

Citations per year, relative to Arzu Gunes Arzu Gunes (= 1×) peers Jesús Novalbos

Countries citing papers authored by Arzu Gunes

Since Specialization

Citations

This map shows the geographic impact of Arzu Gunes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arzu Gunes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arzu Gunes more than expected).

Fields of papers citing papers by Arzu Gunes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arzu Gunes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arzu Gunes. The network helps show where Arzu Gunes may publish in the future.

Co-authorship network of co-authors of Arzu Gunes

This figure shows the co-authorship network connecting the top 25 collaborators of Arzu Gunes. A scholar is included among the top collaborators of Arzu Gunes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arzu Gunes. Arzu Gunes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gökalp, Osman, Arzu Gunes, Hakan Çam, et al.. (2011). Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting. European Journal of Clinical Pharmacology. 67(12). 1223–1229. 26 indexed citations

Melkersson, Kristina, Arzu Gunes, & Marja‐Liisa Dahl. (2010). Impact of serotonin receptor 2A gene haplotypes on C‐peptide levels in clozapine‐ and olanzapine‐treated patients. Human Psychopharmacology Clinical and Experimental. 25(4). 347–352. 14 indexed citations

Dahl, Marja‐Liisa & Arzu Gunes. (2010). Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics. Pharmaceuticals. 3(4). 782–794. 7 indexed citations

Liou, G. I., Azza B. El‐Remessy, Ahmed S. Ibrahim, et al.. (2009). Cannabidiol as a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. Current pharmacogenomics and personalized medicine (Online). 7(3). 215–222. 10 indexed citations

Gunes, Arzu, Kristina Melkersson, Maria Gabriella Scordo, & Marja‐Liisa Dahl. (2009). Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine. Journal of Clinical Psychopharmacology. 29(1). 65–68. 66 indexed citations

Gladding, Patrick, Mark Webster, Irene Zeng, et al.. (2008). The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response. JACC: Cardiovascular Interventions. 1(6). 620–627. 93 indexed citations

Gladding, Patrick, Mark Webster, Irene Zeng, et al.. (2008). The Antiplatelet Effect of Higher Loading and Maintenance Dose Regimens of Clopidogrel. JACC: Cardiovascular Interventions. 1(6). 612–619. 45 indexed citations

Gunes, Arzu, Marja‐Liisa Dahl, Edoardo Spina, & Maria Gabriella Scordo. (2008). Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients. European Journal of Clinical Pharmacology. 64(5). 477–482. 47 indexed citations

Gunes, Arzu & Marja‐Liisa Dahl. (2008). Variation in CYP1A2 Activity and its Clinical Implications: Influence of Environmental Factors and Genetic Polymorphisms. Pharmacogenomics. 9(5). 625–637. 202 indexed citations

10.

Gunes, Arzu, Edoardo Spina, Marja‐Liisa Dahl, & Maria Gabriella Scordo. (2008). ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety. Therapeutic Drug Monitoring. 30(5). 628–633. 45 indexed citations

11.

Uluoğlu, Canan, Gül Özbey, Çi̇men Karasu, et al.. (2008). The effect of experimental diabetes on the circadian pattern of adenosine deaminase and myeloperoxidase activities in rat liver.. PubMed. 27(1). 25–31. 5 indexed citations

12.

Zeng, Irene, James T. Stewart, P. Ruygrok, et al.. (2008). THE PHARMACOGENOMICS AND PHARMACODYNAMICS OF CLOPIDOGREL RESPONSE: AN ANALYSIS FROM THE PRINC (PLAVIX RESPONSE IN CORONARY INTERVENTION) TRIAL. Heart Lung and Circulation. 17. S2–S2. 2 indexed citations

13.

Uluoğlu, Canan, et al.. (2007). The Effect of Experimental Diabetes on the Twenty‐Four‐Hour Pattern of the Vasodilator Responses to Acetylcholine and Isoprenaline ın the Rat Aorta. Chronobiology International. 24(6). 1081–1094. 4 indexed citations

14.

Gunes, Arzu, Erhan Bilir, Hakan Zengil, et al.. (2007). Inhibitory Effect of Valproic Acid on Cytochrome P450 2C9 Activity in Epilepsy Patients. Basic & Clinical Pharmacology & Toxicology. 100(6). 383–386. 33 indexed citations

15.

Melkersson, Kristina, M.G. Scordo, Arzu Gunes, & Marja‐Liisa Dahl. (2007). Impact of CYP1A2 and CYP2D6 Polymorphisms on Drug Metabolism and on Insulin and Lipid Elevations and Insulin Resistance in Clozapine-Treated Patients. The Journal of Clinical Psychiatry. 68(5). 697–704. 53 indexed citations

16.

Yaşar, Ümit, Arzu Gunes, Melih O. Babaoğlu, et al.. (2007). Inhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patients. The FASEB Journal. 21(6). 1 indexed citations

17.

Gunes, Arzu, Uğur Çoşkun, Nazan Günel, et al.. (2006). Inhibitory Effect of 5‐Fluorouracil on Cytochrome P450 2C9 Activity in Cancer Patients. Basic & Clinical Pharmacology & Toxicology. 98(2). 197–200. 30 indexed citations

18.

Gunes, Arzu, et al.. (2006). Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients. Psychopharmacology. 190(4). 479–484. 47 indexed citations

19.

Özdemir, Vural, Arzu Gunes, Marja‐Liisa Dahl, et al.. (2006). Could Endogenous Substrates of Drug-Metabolizing Enzymes Influence Constitutive Physiology and Drug Target Responsiveness?. Pharmacogenomics. 7(8). 1199–1210. 14 indexed citations

20.

Ulusu, Nuriye Nuray, Gül Özbey, Arzu Gunes, et al.. (2005). Circadian Variations in the Activities of 6‐Phosphogluconate Dehydrogenase and Glucose‐6‐Phosphate Dehydrogenase in the Liver of Conrol and Streptozotocin‐Induced Diabetic Rats. Chronobiology International. 22(4). 667–677. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact